Related Experiment Video
Updated: Jun 20, 2026

09:05
Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
Published on: April 18, 2016
Two pathways for cyclooxygenase-2 protein degradation in vivo
Masayuki Wada1, Thomas L Saunders, Jason Morrow
1Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
The Journal of Biological Chemistry
|September 18, 2009
Summary
The endoplasmic reticulum-associated degradation pathway limits cyclooxygenase-2 (COX-2) levels in vivo. Deleting a key segment prevents this degradation, leading to elevated COX-2 and altered inflammatory responses.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Cyclooxygenase-2 (COX-2), or prostaglandin endoperoxide H synthase-2 (PGHS-2), is crucial for prostaglandin synthesis.
- COX-2 is implicated in inflammation and overexpressed in colon cancer.
- A specific 18-amino acid segment (residues 595-612) is vital for N-glycosylation and subsequent endoplasmic reticulum-associated degradation (ERAD) of COX-2.
Purpose of the Study:
- To investigate the in vivo significance of the ERAD pathway in regulating COX-2 protein levels.
- To characterize the physiological consequences of impaired COX-2 degradation.
Main Methods:
- Generation of a knock-in mouse model (Delta 18 COX-2) lacking the 18-amino acid segment required for ERAD.
- Analysis of renal, reproductive, and inflammatory phenotypes in Delta 18 COX-2 mice.
- Assessment of COX-2 expression in various tissues and cell types (brain, macrophages, fibroblasts) from knock-in and wild-type mice.
- Investigation of the effects of NSAIDs (flurbiprofen, ibuprofen) on COX-2 degradation.
Main Results:
- Delta 18 COX-2 mice lack the abnormalities seen in COX-2 null mice but exhibit elevated urinary prostaglandin E(2) metabolite levels.
- These mice show a more severe and prolonged febrile response to bacterial endotoxin.
- Overexpression of Delta 18 COX-2 protein was observed in brain, macrophages, and fibroblasts.
- NSAID treatment demonstrated that substrate turnover influences COX-2 degradation, and flurbiprofen attenuates it.
- Constant COX-2 levels in kidneys and spleens suggest compensatory mechanisms.
Conclusions:
- The endoplasmic reticulum-associated degradation pathway is a significant in vivo mechanism for controlling COX-2 levels.
- Impairment of this pathway leads to elevated COX-2 and altered inflammatory responses.
- Substrate turnover plays a role in COX-2 degradation, modulated by NSAIDs.
- Compensatory mechanisms exist to maintain COX-2 homeostasis in specific tissues like the kidney and spleen.
Related Concept Videos
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
